GleamWall
中文EN

TCRG Cannaisseur Group Inc.

Medicinal Chemicals & Botanical Products · OTC · SEC CIK 1879270 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY78.2%
TTM EPS YoY100.0%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE—
ROA-162,372.1%
ROIC (approx.)—
Asset turnover0.00x

Leverage & solvency

Liabilities / assets2,151,675.0%
Debt / equity—
Current ratio0.00x
Interest coverage-403.02x

Cash quality & payout

Operating cash flow / net income0.28x
Accruals ratio-116,771.7%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$0$0$0$0$0$0$0$0
Cost of revenue$0$118$0$192$272$282$164$1,113
Gross profit$0-$118$0-$192-$272-$282-$164-$1,113
SG&A expense$85,191$94,708$102,257$101,211$690,209$77,207$846,908$88,274
Operating income-$85,191-$94,826-$102,257-$101,403-$690,481-$77,489-$847,072-$89,387
Interest expense$237$237$238$240$686$1,640$1,711$1,701
Pretax income-$85,428-$95,063-$102,495-$101,643-$778,824-$79,129-$848,783-$91,088
Income tax$0$0$0$0$0$0$0$0
Net income-$85,312-$94,889-$102,378-$101,431-$745,167-$78,732-$848,583-$90,433
EBITDA———————-$89,387
EPS (basic)0.000.000.00—-0.010.00-0.02—
EPS (diluted)0.000.000.00—-0.010.00-0.02—
Weighted avg. shares (diluted)60.46M60.46M60.45M—57.18M49.91M47.88M—
Balance sheet
Cash & equivalents$20$41$45$22$143$2,558$20,400$563
Receivables———$0$0$0$285$285
Inventory$0$0$118$118$310$582$864$1,028
Current assets$20$41$163$140$453$3,140$21,549$1,876
Total assets$20$41$163$140$453$3,140$21,549$1,876
Current liabilities$406,051$338,278$273,580$210,632$128,894$408,164$347,733$229,113
Total liabilities$430,335$362,735$298,209$235,431$153,861$433,298$384,032$305,576
Shareholders' equity-$287,506-$220,001-$155,527-$92,889-$11,218-$359,500-$292,222-$233,639
Shares outstanding60.46M60.46M60.46M60.46M60.46M49.76M49.98M44.34M
Cash flow statement
Operating cash flow-$17,828-$30,419-$39,717-$19,881-$21,065-$17,842-$68,663-$12,469
Financing cash flow$17,807$30,415$39,740$19,760$18,650$0$88,500$12,500
Depreciation & amortization———————$0
Stock-based compensation$0$0$0$0$592,962$0$700,000$0

Free plan shows the latest 8 periods; Pro shows all 19 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.